<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211201053244N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-12</date_registration>
      <primary_sponsor>University of Sistan and Baluchistan</primary_sponsor>
      <public_title>Comparing the Effects of Different Exercise Programs for Chronic Back Pain in Middle-Aged Women</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Pilates, Pelvic Floor Training, and Combined Programs on Pain and Function in Middle-Aged Women with Chronic Low Back Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/91430</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: No additional unique design features. Standard parallel-group RCT with supervised interventions and blinded outcome assessment. Control group receives no structured exercise, Randomization description: Participants will be assigned to one of four groups (Pilates, Pelvic Floor Muscle Training (PFMT), Combined Program, or Control) using a simple randomization method with a 1:1:1:1 allocation ratio. The randomization sequence will be generated using a random number table created by SPSS software (version 26) prior to the start of the study. The unit of randomization is the individual participant. To ensure allocation concealment, the generated sequence will be placed into opaque, sealed, and sequentially numbered envelopes by an independent researcher who is not involved in the recruitment, assessment, or intervention process. After the baseline assessments (pre-test) are completed, the next envelope in the sequence will be opened by the same independent researcher, who will then inform the participant of their group allocation. Neither the outcome assessor nor the participants will have access to the randomization list or the contents of the unopened envelopes, Blinding description: Single Blind (Outcome assessor blinded to group allocation; participants and care providers cannot be blinded due to the nature of exercise interventions). To maintain blinding, the outcome assessor will not be present during the intervention sessions, will have no access to the randomization list, and participants will be instructed not to discuss their group assignment with the assessor during the post-test assessments.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic nonspecific low back pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Pilates Exercise Program: An 8-week mat Pilates exercise program consisting of 3 sessions per week, each lasting 50-60 minutes. The program includes a 10-minute warm-up, 30-40 minutes of mat Pilates exercises focusing on deep core muscle activation (transversus abdominis, multifidus, diaphragm, and oblique muscles), spinal stabilization, and controlled breathing, followed by a 5-10 minute cool-down and stretching. Exercise intensity progresses gradually from simple supine and quadruped positions to more challenging sitting and standing positions. All sessions are supervised by a trained Pilates instructor. Intervention 2: Intervention group 2: Pelvic Floor Muscle Training Program: An 8-week pelvic floor muscle training program consisting of 3 sessions per week, each lasting 30-45 minutes. The program includes voluntary, controlled, and repetitive contractions of the pelvic floor muscles, initially performed in simple positions (supine and sitting) and progressing to more functional positions (standing). Training includes sustained contractions (5-10 seconds), rapid contractions, and breathing coordination exercises. Intensity progresses gradually. Emphasis is placed on preventing compensatory movements by superficial abdominal and gluteal muscles. All sessions are supervised by a trained therapist. Intervention 3: Intervention group 3: Combined Program (Pilates + Pelvic Floor Muscle Training): An 8-week combined program integrating Pilates exercises and pelvic floor muscle training, consisting of 3 sessions per week, each lasting 60 minutes. Pelvic floor muscle training is incorporated as part of neuromuscular preparation at the beginning of each session and integrated throughout Pilates movements. The program emphasizes coordination between pelvic floor muscles and deep core muscles, regulation of intra-abdominal pressure, and improvement of lumbopelvic motor control. Exercise intensity and complexity progress gradually from stable to more challenging positions. All sessions are supervised by a trained instructor. Intervention 4: Control Group: No Structured Exercise: Participants in the control group do not receive any structured exercise intervention during the 8-week study period. They are advised to maintain their usual daily activities and avoid starting any new exercise programs or similar therapeutic interventions during the study period. At the end of the study, an appropriate exercise program will be offered to them educationally upon request.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is The deidentified individual participant data (IPD) collected in this study will not be publicly available due to ethical and privacy considerations. However, the study protocol, statistical analysis plan, informed consent form, and clinical study report will be made available to other researchers upon reasonable request to the corresponding author. Data sharing requests will be reviewed by the research team and the ethics committee of the University of Sistan and Baluchestan to ensure compliance with ethical standards and participant privacy. Access to IPD may be granted for meta-analyses or systematic reviews with a valid scientific rationale, subject to a data sharing agreement. All shared data will be fully anonymized to protect participant identities. The analytic code and data dictionary may be shared upon request after the completion and publication of the study results.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Rezaeipor</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Sistan and Baluchestan housing</address>
        <city>ZAhedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816745639</zip>
        <telephone>+98 54 3113 6727</telephone>
        <email>rezaeipour@ped.usb.ac.ir</email>
        <affiliation>University of Sistan and Baluchestan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Rezaeipour.</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University Professors' Neighborhood of Sistan and Baluchestan University.</address>
        <city>Zahedan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9816745639</zip>
        <telephone>+98 54 3113 2674</telephone>
        <email>rezaeipour@ped.usb.ac.ir</email>
        <affiliation>University of Sistan and Baluchistan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Female gender and age between 40 and 65 years.
Diagnosis of chronic nonspecific low back pain (CNSLBP) with a history of pain lasting more than 12 weeks.
Pain intensity of at least 3 out of 10 on the Visual Analog Scale (VAS) at the time of enrollment.
Ability to perform moderate physical activity and no medical contraindication for exercise.
Willingness to participate and provide written informed consent.</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of spinal, pelvic, or lower limb surgery.
History of specific spinal pathologies (e.g., tumors, infections, fractures, inflammatory disorders).
Presence of severe neurological signs or clinical radiculopathy (e.g., significant muscle weakness, sensory loss).
Pregnancy or childbirth in the last 6 months.
Concurrent participation in another structured exercise or physical therapy program.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Pilates Exercise Program: An 8-week mat Pilates exercise program consisting of 3 sessions per week, each lasting 50-60 minutes. The program includes a 10-minute warm-up, 30-40 minutes of mat Pilates exercises focusing on deep core muscle activation (transversus abdominis, multifidus, diaphragm, and oblique muscles), spinal stabilization, and controlled breathing, followed by a 5-10 minute cool-down and stretching. Exercise intensity progresses gradually from simple supine and quadruped positions to more challenging sitting and standing positions. All sessions are supervised by a trained Pilates instructor.</i_keyword>
      <i_keyword>Intervention group 2: Pelvic Floor Muscle Training Program: An 8-week pelvic floor muscle training program consisting of 3 sessions per week, each lasting 30-45 minutes. The program includes voluntary, controlled, and repetitive contractions of the pelvic floor muscles, initially performed in simple positions (supine and sitting) and progressing to more functional positions (standing). Training includes sustained contractions (5-10 seconds), rapid contractions, and breathing coordination exercises. Intensity progresses gradually. Emphasis is placed on preventing compensatory movements by superficial abdominal and gluteal muscles. All sessions are supervised by a trained therapist.</i_keyword>
      <i_keyword>Intervention group 3: Combined Program (Pilates + Pelvic Floor Muscle Training): An 8-week combined program integrating Pilates exercises and pelvic floor muscle training, consisting of 3 sessions per week, each lasting 60 minutes. Pelvic floor muscle training is incorporated as part of neuromuscular preparation at the beginning of each session and integrated throughout Pilates movements. The program emphasizes coordination between pelvic floor muscles and deep core muscles, regulation of intra-abdominal pressure, and improvement of lumbopelvic motor control. Exercise intensity and complexity progress gradually from stable to more challenging positions. All sessions are supervised by a trained instructor.</i_keyword>
      <i_keyword>Control Group: No Structured Exercise: Participants in the control group do not receive any structured exercise intervention during the 8-week study period. They are advised to maintain their usual daily activities and avoid starting any new exercise programs or similar therapeutic interventions during the study period. At the end of the study, an appropriate exercise program will be offered to them educationally upon request.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: Baseline (before intervention) and immediately after 8 weeks of intervention (post-test). Method of measurement: Visual Analogue Scale (VAS) - a 10-centimeter line where 0 indicates no pain and 10 indicates the worst imaginable pain; participants mark their current pain level on the line.</prim_outcome>
      <prim_outcome>Functional disability. Timepoint: Baseline (before intervention) and immediately after 8 weeks of intervention (post-test). Method of measurement: Oswestry Disability Index (ODI) - a validated 10-item questionnaire assessing the impact of low back pain on daily activities, including personal care, lifting, walking, sitting, standing, sleeping, social life, traveling, and employment; each item scored 0 to 5; total score converted to percentage (0-100%).</prim_outcome>
      <prim_outcome>Trunk muscle endurance. Timepoint: Baseline (before intervention) and immediately after 8 weeks of intervention (post-test). Method of measurement: McGill Core Endurance Tests - three timed tests including: (1) Trunk flexor endurance test (holding a 60-degree sit-up position); (2) Trunk extensor endurance test (holding a prone position with upper body unsupported); (3) Side-bridge endurance test (holding a side-lying plank position). Holding time in seconds is recorded for each test.</prim_outcome>
      <prim_outcome>Motor control. Timepoint: Baseline (before intervention) and immediately after 8 weeks of intervention (post-test). Method of measurement: Active Straight Leg Raise (ASLR) test - participant lies supine and is asked to actively lift one leg straight up without bending the knee; the quality and ease of movement are scored on a 6-point scale (0-5) where 0 indicates no difficulty and 5 indicates impossible to perform; both legs are assessed separately.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Health-related quality of life. Timepoint: Baseline (before intervention) and immediately after 8 weeks of intervention (post-test). Method of measurement: Short Form Health Survey (SF-36) - a 36-item validated questionnaire assessing physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health; each domain scored 0-100, with higher scores indicating better quality of life.</sec_outcome>
      <sec_outcome>Fear of movement. Timepoint: Baseline (before intervention) and immediately after 8 weeks of intervention (post-test). Method of measurement: Tampa Scale for Kinesiophobia (TSK) - a 17-item validated questionnaire assessing fear of movement and (re)injury; each item scored 1-4; total score ranges from 17 to 68, with higher scores indicating greater fear of movement.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Sistan and Baluchistan</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-06-16</approval_date>
        <contact_name>Ethics Committee of the University of Sistan and Baluchestan</contact_name>
        <contact_address>University Blvd., University of Sistan and Baluchestan, Zahedan, Sistan and Baluchestan Province, Iran Zahedan Sistan-va-Balouchestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
